BeiGene Ltd. American Depositary Shares. Replay the stock market charts of BGNE day by day, back to 2003. Open long and short positions without spending any money. BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent.
